Wells Fargo’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.5K | Sell |
6,500
-11,000
| -63% | -$83.8K | ﹤0.01% | 5090 |
|
|
2025
Q1 | $57.1K | Buy |
17,500
+10,690
| +157% | +$34.8K | ﹤0.01% | 4907 |
|
|
2024
Q4 | $30.6K | Buy |
+6,810
| New | +$30.6K | ﹤0.01% | 5139 |
|
|
2024
Q2 | – | Sell |
-7,519
| Closed | -$40.8K | – | 6916 |
|
|
2024
Q1 | $40.8K | Buy |
7,519
+5,931
| +373% | +$32.1K | ﹤0.01% | 4961 |
|
|
2023
Q4 | $8.61K | Buy |
1,588
+373
| +31% | +$2.02K | ﹤0.01% | 5428 |
|
|
2023
Q3 | $10.7K | Buy |
+1,215
| New | +$10.7K | ﹤0.01% | 5422 |
|